EDWARD P. BALABAN, D.O.; RICHARD G. SHEEHAN, M.D.; PETER E. LIPSKY, M.D.; EUGENE P. FRENKEL, M.D.
▸Requests for reprints should be addressed to Edward P. Balaban, D.O.; Department of Internal Medicine, University of Texas Health Science Center, 5323 Harry Hines Blvd.; Dallas, TX 75235.
BALABAN E., SHEEHAN R., LIPSKY P., FRENKEL E.; Treatment of Cutaneous Sclerosis and Aplastic Anemia with Antithymocyte Globulin. Ann Intern Med. 1987;106:56-58. doi: 10.7326/0003-4819-106-1-56
Download citation file:
Published: Ann Intern Med. 1987;106(1):56-58.
We administered antithymocyte globulin to a 52-year-old man with cutaneous sclerosis (scleroderma) and severe aplastic anemia for treatment of the aplastic lesion. The use of this therapy resulted not only in marrow recovery but also in resolution of the sclerosis. This observation indicates that T lymphocytes, their products, or both, are important factors in the pathogenesis of cutaneous sclerosis. Furthermore, the success of this treatment could play a role in future investigations involving the treatment of scleroderma and scleroderma-like conditions.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Hematology/Oncology, Red Cell Disorders.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only